BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 28, 2003
View Archived Issues
NCI to evaluate TNFerade for rectal cancer
Read More
TaiGen receives funding for SARS drug development efforts
Read More
Anti-TNF-alpha antisense oligonucleotide effective and safe in rheumatoid arthritis
Read More
Polyphenon E (EGCg) improves preaged and damaged facial skin
Read More
Alefacept therapy beneficial in the treatment of psoriasis
Read More
CTLA-4Ig reported to improve quality of life and physical function in rheumatoid arthritis
Read More
Statins in the prevention of atherosclerosis caused by SLE
Read More
Novel Kv1.3 channel blockers with utility in multiple sclerosis and other immune disorders
Read More
Nonpeptide GnRH antagonists and their use claimed by Ferring
Read More
Novel elastase inhibitors prepared and tested by Dainippon scientists
Read More
Meiji Milk and Kitasato Institute researchers discover new agents for flu
Read More
Meiji Milk patent describes a cholesterol-lowering peptide
Read More
Two series of MEK inhibitors identified at Array BioPharma
Read More
New antifungal agents, their isolation and biological evaluation claimed by Sankyo
Read More
Kyowa Hakko presents urethra-selective agents for urinary incontinence therapy
Read More
Safety and pharmacokinetics of single-dose MEDI-522 in rheumatoid arthritis
Read More
LibiGel meets endpoints in interim analysis of phase II trial for FSD
Read More
Aventis submits complete response for Ketek
Read More
Shareholder approval for Cell Therapeutics/Novuspharma merger
Read More
FDA schedules advisory committee review date for Ranexa
Read More
IBC enters research collaboration with Schering for cancer
Read More
Stalevo approved for Parkinson's disease in E.U.
Read More
Teva to commercialize OrCel in Israel
Read More
Studies support antiinflammatory, osteogenic and muscle-healing properties of BPC-157
Read More
OSI-7904L evaluated in new phase II study for gastric cancer
Read More
TA-CD advances into phase IIb for cocaine addiction
Read More
Antitumor agent CCI-779 as potential therapy for RA patients
Read More
Preclinical efficacy, safety and PK data discussed for IDN-6556 at AASLD meeting
Read More